News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
780,282 Results
Type
Article (79618)
Company Profile (374)
Press Release (700288)
Multimedia
Podcasts (133)
Webinars (19)
Section
Business (206703)
Career Advice (3493)
Deals (37599)
Drug Delivery (128)
Drug Development (88214)
Employer Resources (187)
FDA (17760)
Job Trends (16401)
News (362971)
Policy (37894)
Tag
Academia (2992)
Academic (1)
Accelerated approval (11)
Adcomms (32)
Allergies (105)
Alliances (52745)
ALS (119)
Alzheimer's disease (1565)
Antibody-drug conjugate (ADC) (184)
Approvals (17711)
Artificial intelligence (365)
Autoimmune disease (35)
Automation (18)
Bankruptcy (383)
Best Places to Work (12428)
BIOSECURE Act (22)
Biosimilars (135)
Biotechnology (254)
Bladder cancer (100)
Brain cancer (39)
Breast cancer (385)
Cancer (3061)
Cardiovascular disease (247)
Career advice (2964)
Career pathing (34)
CAR-T (209)
CDC (40)
Cell therapy (560)
Cervical cancer (24)
Clinical research (72137)
Collaboration (1105)
Company closure (3)
Compensation (710)
Complete response letters (33)
COVID-19 (2898)
CRISPR (67)
C-suite (351)
Cystic fibrosis (120)
Data (3073)
Decentralized trials (2)
Denatured (41)
Depression (75)
Diabetes (377)
Diagnostics (6883)
Digital health (25)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (157)
Drug pricing (150)
Drug shortages (36)
Duchenne muscular dystrophy (132)
Earnings (80929)
Editorial (48)
Employer branding (25)
Employer resources (163)
Events (116609)
Executive appointments (908)
FDA (19477)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1002)
Gene editing (147)
Generative AI (29)
Gene therapy (431)
GLP-1 (932)
Government (5168)
Grass and pollen (6)
Guidances (181)
Healthcare (20697)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (183)
Immuno-oncology (10)
Indications (40)
Infectious disease (3093)
Inflammatory bowel disease (164)
Inflation Reduction Act (12)
Influenza (70)
Intellectual property (124)
Interviews (664)
IPO (17491)
IRA (54)
Job creations (4402)
Job search strategy (2432)
Kidney cancer (14)
Labor market (51)
Layoffs (589)
Leadership (26)
Legal (9424)
Liver cancer (85)
Lung cancer (431)
Lymphoma (215)
Machine learning (11)
Management (64)
Manufacturing (430)
MASH (99)
Medical device (14537)
Medtech (14542)
Mergers & acquisitions (20850)
Metabolic disorders (960)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (139)
Neuropsychiatric disorders (40)
Neuroscience (2311)
NextGen: Class of 2025 (7417)
Non-profit (5047)
Now hiring (46)
Obesity (494)
Opinion (289)
Ovarian cancer (104)
Pain (120)
Pancreatic cancer (125)
Parkinson's disease (199)
Partnered (24)
Patents (317)
Patient recruitment (170)
Peanut (55)
People (61499)
Pharmaceutical (83)
Pharmacy benefit managers (25)
Phase I (22130)
Phase II (31396)
Phase III (23732)
Pipeline (1691)
Policy (239)
Postmarket research (3371)
Preclinical (9824)
Press Release (69)
Prostate cancer (149)
Psychedelics (45)
Radiopharmaceuticals (272)
Rare diseases (521)
Real estate (6658)
Recruiting (76)
Regulatory (26036)
Reports (50)
Research institute (2642)
Resumes & cover letters (559)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (98)
Series A (172)
Series B (118)
Service/supplier (20)
Sickle cell disease (66)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (37)
Startups (4042)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (65)
The Weekly (90)
Vaccines (912)
Venture capital (57)
Weight loss (329)
Women's health (52)
Worklife (20)
Date
Today (76)
Last 7 days (399)
Last 30 days (1976)
Last 365 days (33172)
2025 (17859)
2024 (37260)
2023 (42172)
2022 (53492)
2021 (58212)
2020 (57127)
2019 (50725)
2018 (38630)
2017 (36154)
2016 (36203)
2015 (41661)
2014 (35004)
2013 (32759)
2012 (33030)
2011 (33302)
2010 (32367)
Location
Africa (1121)
Alabama (68)
Alaska (7)
Arizona (239)
Arkansas (14)
Asia (46740)
Australia (8163)
California (7656)
Canada (2391)
China (724)
Colorado (331)
Connecticut (344)
Delaware (199)
Europe (108660)
Florida (1151)
Georgia (255)
Hawaii (2)
Idaho (66)
Illinois (705)
India (29)
Indiana (374)
Iowa (17)
Japan (236)
Kansas (114)
Kentucky (30)
Louisiana (17)
Maine (73)
Maryland (1087)
Massachusetts (5811)
Michigan (260)
Minnesota (473)
Mississippi (3)
Missouri (100)
Montana (32)
Nebraska (25)
Nevada (82)
New Hampshire (72)
New Jersey (2138)
New Mexico (31)
New York (2149)
North Carolina (1210)
North Dakota (10)
Northern California (3337)
Ohio (246)
Oklahoma (17)
Oregon (38)
Pennsylvania (1641)
Puerto Rico (18)
Rhode Island (39)
South America (1506)
South Carolina (36)
South Dakota (1)
Southern California (2858)
Tennessee (129)
Texas (1170)
United States (28761)
Utah (229)
Virginia (203)
Washington D.C. (79)
Washington State (665)
West Virginia (4)
Wisconsin (79)
780,282 Results for "st michael s hospital".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
St. Michael’s Hospital Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that a research team from St. Michael’s Hospital, a site of Unity Health Toronto, has joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
April 16, 2024
·
5 min read
Career Advice
Leadership Lab: 5 Ways Biopharma Execs Can Restore Trust, Retain Talent After Layoffs
In the latest installment of his column, Kaye/Bassman’s Michael Pietrack shares five ways leaders can help their teams after a layoff, from acknowledging emotions to reestablishing culture.
June 25, 2025
·
4 min read
·
Michael Pietrack
Press Releases
OneOncology Appoints Dr. Michael Byrne as Medical Director for Cellular Therapy
July 8, 2025
·
3 min read
World’s First Wearable Ultrasound Patch in use for sepsis care at a Toronto Hospital
FloPatch, a wearable ultrasound device, is in use in two critical care units at St. Michael’s Hospital.
June 5, 2024
·
2 min read
Press Releases
Children’s Hospital of Philadelphia and St. Jude Researchers Find Genetic Ancestry Influences How Gene Mutations Impact Cancer Prognosis in Patients With T-cell Acute Lymphoblastic Leukemia
June 24, 2025
·
6 min read
Press Releases
Stratus Therapeutics Strengthens Executive Team with Appointment of Michael P. Cooke, PhD as Chief Scientific Officer
June 2, 2025
·
3 min read
Brain Cancer Canada Awards St. Michael’s Hospital $100,000 Grant for Advanced DNA Sequencer Technology
Brain Cancer Canada, the country’s leading charitable organization dedicated to brain cancer research, has announced a $100,000 grant to St. Michael’s Hospital, a site of Unity Health Toronto.
May 31, 2023
·
2 min read
Press Releases
Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change
July 4, 2025
·
6 min read
Press Releases
Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development
June 11, 2025
·
6 min read
Leadership
Leading From the Front: 3 Leadership Lessons From Mark Cuban
Businessman and entrepreneur Mark Cuban recently discussed leadership with Leadership Lab columnist Michael Pietrack. The three lessons that came out of that conversation start with one word: caring.
December 17, 2024
·
6 min read
·
Michael Pietrack
1 of 78,029
Next